Drug Shortage Report for KADIAN
| Report ID | 143126 |
| Drug Identification Number | 02184443 |
| Brand name | KADIAN |
| Common or Proper name | MORPHINE SULFATE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-09-07 |
| Actual start date | 2021-08-09 |
| Estimated end date | 2021-10-19 |
| Actual end date | 2021-10-20 |
| Shortage status | Resolved |
| Updated date | 2021-10-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-10-26 | French | Compare |
| v5 | 2021-10-26 | English | Compare |
| v4 | 2021-08-18 | French | Compare |
| v3 | 2021-08-18 | English | Compare |
| v2 | 2021-07-28 | French | Compare |
| v1 | 2021-07-28 | English | Compare |
Showing 1 to 6 of 6